Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03834688
Title Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PrECOG, LLC.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Carle Cancer Center Urbana Illinois 61801 United States Details
Indiana University Simon Cancer Center Indianapolis Indiana 46202 United States Details
St. Joseph Mercy Hospital Cancer Care Center Ann Arbor Michigan 48106 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University School of Medicine Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
Reading Hospital/McGlinn Cancer Institute West Reading Pennsylvania 19611 United States Details
University of Virginia Health System Charlottesville Virginia 22903 United States Details
Gundersen Health System La Crosse Wisconsin 54601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field